About
The Nanobioengineering group is a truly multidisciplinary team composed by researchers coming from very diverse backgrounds working together in applying nanotechnology for the development of new biomedical systems and devices, mainly for diagnostic purposes, and integrated microfluidic Organ-on-Chip devices for the study of organ physiology, disease etiology, or drug screening.
The goal is to fabricate microsystems containing living cells that recapitulate tissue and organ level functions in vitro and new portable diagnosis devices that can be used as Point-of-Care systems.
The main research activities of the group include the engineering and biochemical functionalization of biomaterials integrated with microfluidics systems. The bioengineered microdevices are used to study cell responses to biomolecular compounds applied to Organ-on-Chip devices, or for the development of new lab-on-a-chip based biosensors.
The projects carried out by the group are focused on clinical and industrial problems and are related to three convergent research lines:
1. Biosensors and Lab-on-a-Chip devices for clinical diagnosis and monitoring
- DNA sensors-arrays integrated in lab-on-a-chip for portable point of care diagnosis
- Vascular implantable sensors for circular cancer biomarker detection.
- Antibody-based sensors for pathogenic microorganisms’ detection and neurodegenerative early detection
- Implantable physiological sensors-array for tissue in vivo hypoxia and ischemia monitoring.
- 3D printing microfluidic technology.
- Microfluidic chip using hydrodynamic forces for cell counting and sorting. Application for detection of circulating tumours cells (CTCs).
2. Nanotechnology applied to biomolecule interaction studies and micro/nano-environments for regenerative medicine applications
- Development of bioengineered 2D and 3D micro/nanoenvironments with a topography and chemical composition controlled at the nanoscale for cell behavior studies (adhesion, proliferation, differentiation). Application to musculoskeletal system regeneration.
- Biophysical description of cellular phenomena (adhesion, cell migration, differentiation) using micro/nanotechnologies, cell biology tools and soft matter physics.
- Study of biological mechanisms at single molecule level.
- Study of magnetite nanoparticles – Amyloid-Beta interaction in Alzheimer disease.
3. Microfluidic systems for biological studies and Organ-on-Chip devices
- Microfluidic chip for blood/plasma filtering and anemia diseases characterization
- Spleen-on-a-chip development.
- Nanoporous-based systems for kidney-on–a-chip developments.
- Engineering microfluidic platforms for neurobiological studies.
- Development of 3D neuromuscular tissue models for soft robotics and clinical applications
- Microfluidic system to monitor cancer therapy response. Tumor Cancer on a chip in vitro development.
- Microfluidic vessel on-a-chip for screening drug delivery systems.
Staff
ibecbarcelona.euProjects
| NATIONAL PROJECTS | FINANCER | PI |
|---|---|---|
| BASE3D (2019-2022) | RIS3CAT Tecnologies Emergents | Josep Samitier |
| PREMED Desarrollo de un ensayo microfluídico funcional en células para el tratamiento personalizado contra el cáncer (2019-2022) | MICIU: Retos investigación | Joan Montero |
| Sistema microfisiológico para mimetizar las barreras hemato-sistema nervioso central: aplicación a la esclerosis lateral amiotrófica (2019-2022) | MICIU: Retos investigación | Anna Lagunas |
| BATMAN Nanopartículas biomiméticas para el tratamiento dirigido del neuroblastoma pediátrico (2021-2023) | MICIU, Retos investigación: Proyectos I+D. | Aranzazu Villasante |
| Neuroblastoma en un chip para investigar la resistencia a fármacos y el uso de nanopartículas terapéuticas (2018-2022) | Asociación Española contra el Cáncer (AECC) | Aranzazu Villasante |
| Evaluación Funcional de respuesta celular a la quimioterapia neoadyuvante en Sarcoma de tejido blando (2021-2024) | Fundación Mari Paz Jiménez Casado (FMPJC), Beca Trienal FMPJC Investigación Sarcomas | Joan Montero |
| INTERNATIONAL PROJECTS | FINANCER | PI |
|---|---|---|
| ASCTN-Training Training on Advanced Stem Cell Technologies in Neurology (2018-2022) | European Comission Marie Curie ITN | Josep Samitier |
| EVIDENCE Erythrocytes properties and viability in dependence of flow and extra-cellular environment (2020-2023) | European Comission Marie Curie ITN | Josep Samitier |
| PANDORA Pandemics Outbreaks Rationalized: towards a universal therapy to eliminate intracellular pathogens (2020-2025) | European Commission, ERC – StG | Josep Samitier |
| BEST Postdoctoral Programme in Bioengineering Excellence Scientific Training (2017-2022) | European Commission, COFUND – Marie Sklodowska-Curie Co-funding of regional, national and international programmes | Josep Samitier |
| SCIFI From Scientists to Innovators for Industry (2022-2024) | EIT Health, EITHealth BP2022 Education | Josep Samitier |
| PRIVATELY-FUNDED PROJECTS | FINANCER | PI |
|---|---|---|
| Descubrimiento de nuevos marcadores terapéuticos en neuroblastoma mediante la generación de modelos basados en técnicas de ingeniería de cáncer (2021-2023) | Associació pacients NEN | Josep Samitier /Aranzazu Villasante |
| Understanding and measuring mechanical tumor properties to improve cancer diagnosis, treatment, and survival: Application to liquid biòpsies (2017-2022) | Obra Social La Caixa | Josep Samitier |
| BCNatal Artificial Placenta Project (2021-2022) | Obra Social La Caixa | Maria José López |
| Descubrimiento de nuevos marcadores terapéuticos en neuroblastoma mediante la generación de modelos basados en técnicas de ingeniería de cáncer (2021-2023) | Associació pacients NEN | Aranzazu Villasante |
| FINISHED PROJECTS | FINANCER | PI |
|---|---|---|
| Personalizing pediatric cancer treatment with kinome analyses, cell-based funcional assays and microfluidics (2017-2021) | CELLEX | Josep Samitier / Joan Montero |
| ISCHEMSURG Miniaturized electrochemical sensor for monitoring of free flap ischemia in post-surgery (2019-2021) | AGAUR | Josep Samitier |
| Joint Programme – Healthy Ageing (2016) | Obra Social “La Caixa” | Josep Samitier |
| PLANTOID Innovative Robotic Artefacts Inspired by Plant Roots for Soil Monitoring | ICT | Josep Samitier |
| Universal diagnostic platforms based on oligonucleotide cofidied nanoparticles and DNA microarray sensor devices | MINECO, I+D-Investigación fundamental no orientada | Josep Samitier |
| ELECTRA-G (2014-2016) | Conveni GENOMICA S.A.U. | Josep Samitier |
| Desarrollo de una nueva tecnología lab-on-a-chip para la detección y cuantificación de secuencias de ADN/ARN (2014-2016) | Conveni GENOMICA S.A.U. | Josep Samitier |
| BIOBOT Engineered biological soft robots based on neuro-muscular junction control (2015-2018) | MINECO, Proyectos EXPLORA Ciencia / Tecnología 2015 | Josep Samitier |
| Advancecat Acceleradora pel desenvolupament de teràpies avançades | ACCIÓ / Smart Specialization funds (RIS3) | Josep Samitier |
| MINDS Plataforma MIcrofluídica 3D de cultivo Neuronal compartimentada para el estuDio de enfermedades neurológicaS (2016-2018) | MINECO, Proyectos I+D Excelencia | Josep Samitier |
| nanoET-leukemia Nanoconductance of electron transfer proteins of the respiratory chain. Direct measurementat the single molecular level and therapeutic regulation in cancer stem cells (2015-2018) | MINECO, Proyectos RETOS 2015 / CIBER | Anna Lagunas / Marina Giannotti |
| Desenvolupar un sistema d’assistència robòtica per medicina i cirurgia fetal (2016-2019) | CELLEX | Josep Samitier |
| Monitoring neurocognitive deficits in Alzheimer’s and Parkinson’s diseases using saliva or blood-derived biomarkers and a multiplexed approach (2016-2018) | Obra Social “La Caixa” | Josep Samitier |
| ISCHEMSURG Miniaturized electrochemical sensor for monitoring of free flap ischemia in post-surgery (2019-2020) | CaixaImpulse | Monica Mir |
| Personalizing Melanoma Treatment Using Dynamic BH3 Profiling (2018-2020) | Dana-Farber Cancer Institut | Joan Montero |
| NANOVAX Nanovacunas diseñadas para inmunoterapia antitumoral (2016-2020) | EuroNanoMed (ERA-Net) | Josep Samitier |
| Understanding and measuring mechanical tumor properties to improve cancer diagnosis, treatment, and survival: Application to liquid biopsies (2017-2020) | Obra Social “La Caixa” | Josep Samitier |
| Personalizing pediatric cancer treatment (2018-2020) | Fundación FERO | Joan Montero |
Publications
Equipment
Nanofabrication and nanomanipulation
- 3D Printing system for microfluidic devices
- Graphtech
Characterization
- Potentiostates
- Optical Waveguide Lightmode Spectroscope (OWLS)
- Atomic Force Microscope (AFM)
- Optical Microscopes (white light/epifluorescence)
- Electrical Impedance spectroscopy (EIS)
- Multi-frequency Lock-in Amplifier
- Sub-femtoamp Remote SourceMeter Instrument
Molecular/cell biology
- Biological safety cabinet (class II)
- Microwell plate readers
- Protein and DNA electrophoresis systems
- Microincubator Okolab
- Nanodrop spectrophotometer
- CO2 incubator for cells: Galaxy® 48 S, 48 L, 230 V/50/60 Hz, standard
- Cell culture cabin: Bioii-Advance 3
Microfluidics
- High precision syringe pumps
- Peristaltic pumps
Collaborations
- Prof. Fernando Albericio
Institut de Recerca Biomédica (IRB), Barcelona, Spain - Dr. José Antonio Andrades
Universidad de Málaga, Spain - Prof. Ezequiel Pérez
Inestrosa Centro Andaluz de Nanomedicina y Biotecnología (BIONAND), Málaga, Spain - Prof. Joan Bausells
Centro Nacional de Microelectrónica (CNM-CSIC), Barcelona - Prof. Albert van den Berg
University of Twente, The Netherlands - Prof. Andre Bernard
Institut für Mikro- und Nanotechnologie (MNT-NTB), Buchs, Switzerland - Prof. H. Börner
Max Planck Institute of Colloids and Interfaces, Golm, Germany - Prof. Josep Maria Canals
University of Barcelona, Spain - Dr. Matthew Dalby
University of Glasgow, UK - Prof. Paolo Dario
Scuola Superiore Sant’Anna (SSSA), Pontedera, Italy - Prof. Ramón Eritja
Institut de Recerca Biomédica (IRB), Barcelona, Spain - Prof. E. Faszewski
Wheelock College, Boston, USA - Prof. G. Fuhr
FhG Biomedicine, St. Ingbert, Germany - Dr. Juan C. Izpisúa
Salk Institute for Biological Studies, La Jolla, California - Dr. Nicole Jaffrezic
Université Claude Bernard Lyon 1, France - Dr. Graham Johnson
Uniscan Instruments Ltd, Buxton, UK - Dr. Mª Pilar Marco
Institute of Chemical and Environmental Research, Barcelona - Prof. Jean-Louis Marty
Université de Perpignan Via Domitia, France - Prof. Barbara Mazzolai
IIT Center for Micro-BioRobotics (CMBR), Pontedera, Italy - Dr. Edith Pajot
Biology of Olfaction and Biosensors group (BOB) at INRA, Jouy-en-Josas, France - Dr. M. Lluïssa Pérez
Dept. Farmacología, University of Barcelona, Spain - Dr. Hernando del Portillo
Centro de Investigación en Salud Internacional de Barcelona (CRESIB), Barcelona, Spain - Dr. Jaume Reventós
Hospital Vall d’Hebrón, Barcelona, Spain - Prof. L. Reggiani
Nanotechnology Laboratory, INFM, Lecce, Italy - Prof. Daniel Riveline
Laboratory of Cell Physics ISIS/IGBMC, Strasbourg - Prof. M. Sampietro
Politecnico di Milano, Italy - Prof. Molly M. Stevens
Imperial College, London, UK - Dr. Christophe Vieu
Laboratoire d’analyse et d’architectures des systèmes (LAAS-CNRS), Toulouse, France - Prof. Pau Gorostiza
IBEC - Prof. Irene Díaz Moreno
3IIQ-cicCartuja, Universidad de Sevilla-CSIC, Spain - Prof. Miguel A. de la Rosa
3IIQ-cicCartuja, Universidad de Sevilla-CSIC, Spain - Dr. María del Mar Mañú Pereira
Josep Carreras Leukaemia Research Institute, Barcelona, Spain - Dr. Joan Lluis Vives
Josep Carreras Leukaemia Research Institute, Barcelona, Spain
Industry partners:
- Biokit S.A. (Werfen group); Genomica S.A.U. (Zeltia group); Tallers Fiestas S.L.; Enantia S.L.; Microfluidic ChipShop GmbH; Minifab; Microliquid
News
IBEC and VHIR hold a collaboration day to promote synergies
The 1st Translational Collaboration Day between the Vall d’Hebron Institute of Research (VHIR) and the Institute of Bioengineering of Catalonia (IBEC), held on 21st November, was an opportunity to learn about the projects and research lines of both institutions and to promote interaction between professionals.
Advances in nanobiotechnology and nanomedicine explored at the 12th International NanoBio&Med Conference
The latest developments in nanotechnology, biotechnology and medicine were presented at the NanoBio&Med 2024 International Conference, held this week at the Barcelona Science Park (PCB) from 5 to 7 November. This is an annual event designed to establish new collaborations and promote innovative projects in the scientific-industrial sector.
Bioengineering for Emergent and Advanced Therapies at the 17th IBEC Symposium
IBEC’s 17th Annual Symposium focused on ‘Bioengineering for Emergent and Advanced Therapies’, one of IBEC’s key application areas. Around 300 people attended the event, including local and international researchers. It was a multidisciplinary environment in which experts from other centres and the IBEC community itself had the opportunity to present their projects and share knowledge.
IBEC and West China Hospital strengthen collaboration in precision medicine
The second IBEC-WCH Precision Medicine Conference took place last week in Chengdu, China. This is a partnership between the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital (WCH) of Sichuan University, which aims to strengthen scientific collaboration between the two countries.
A study led by IBEC successfully mimics the complex neuroblastoma vasculature on a chip to explore treatments for this pediatric cancer
Two studies led by IBEC have successfully mimicked the transdifferentiation process of the neuroblastoma vasculature in in vitro models. These models, one in 2D and the other on a microfluidic chip, provide platforms for identifying new biomarkers and designing effective therapies against this type of cancer.
Nanomedicine to tackle rare diseases
Experts in nanomedicine from various fields have gathered today for the fifth consecutive year at Nano Rare Diseases Day. This event is co-organized by the NANOMED Spain platform, coordinated by IBEC, and SJD Barcelona Children’s Hospital, showcasing the latest advances in nanomedicine for the diagnosis and treatment of rare diseases.
IBEC Drives Dialogue on Innovations in Personalized Medicine and Emerging Therapies at Barcelona Health Innovation Week
Today, on February 14, IBEC organized the roundtable “Challenges in Innovation in Personalized Medicine and Emerging Therapies.” The event is part of Barcelona Health Innovation Week, organized by Biocat. It fostered a dialogue where experts from diverse fields shared their perspectives on identifying opportunities to propel the utilization of new technologies in the healthcare sector.
Nanomedicine experts gather on World Cancer Nanoday
Once again, experts in nanomedicine from various fields gathered in Barcelona on the occasion of World Cancer Day. The meeting provided an opportunity to showcase the latest innovations in nanomedicine for combating cancer, covering topics such as early diagnosis, controlled drug release, and radiotherapy employing nanoparticles.
Jobs
Research Assistant at the Nanobioengineering Research Group
Ref: RA-JS // Deadline: 26/08/2024
Laboratory Technician at the Nanobioengineering Research Group
Ref: LT_JS/Deadline: 22/01/2024
Predoctoral Researcher at the Bioengineering Research Group
Ref: PhD-JS_//Deadline: 30/09/2023
Predoctoral Researcher at the Nanobioengineering Research Group
Ref: PhD-JS//Deadline: 9/09/2023
Research Assistant at the Nanobioengineering Research Group
Ref: RA_JS// 28/07/2023
Tècnic/-a de Laboratori en el grup Nanobioenginyeria
Ref: LT-JS / Deadline: 15/06/2023
Postdoctoral Researcher at the Nanobioengineering Research Group
Ref: PD_JS / Deadline: 03/04/2023
Senior Technician at the Nanobioengineering Research Group (ST-JS)
Reference: ST-JS / Deadline: 17/03/2023
Postdoctoral researcher at the Nanobioengineering Research Group
Application Deadline: 24/06/2022Ref: PD-JS The Nanobioengineering group led by Dr. Josep Samitier at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Postdoctoral researcher to develop a research and development project on water quality monitoring. The contract will be within the framework of development and characterization of quality water sensors. Funded by “Fundació Bosch i Gimpera”